MeTA - Uganda

Uganda is one of the seven countries taking part in the pilot phase of MeTA. The resources listed below relate specifically to Uganda.

We will add to this key list over time and would welcome suggestions or additions. Please send these to:

Selected resources

Books, reports, etc

Effective drug regulation : a multicountry study


Expand view

This publication presents a synthesis of studies on drug regulation carried out in ten countries: Australia, Cuba, Cyprus, Estonia, Malaysia, the Netherlands, Tunisia, Uganda, Venezuela, and Zimbabwe in 1998-1999. It gives an overview of the development of drug regulation in these countries as well as the resources available and the strategies applied in drug regulation implementation at the time the studies were conducted. An analysis of the strengths and weaknesses in drug regulation in these countries is also provided

Improving management of childhood malaria in Nigeria and Uganda by improving practices of patent medicine vendors

GREER, George
et al

Expand view

"A number of studies from Sub-Saharan African (SSA) have shown that between 15 and 82 per cent of the population choose to first consult private drug shops and informal providers for advice about and assistance with treatment of childhood illnesses. It has also been found for private shops that a large percentage of the drugs provided or dosages given, or both, are inappropriate, indicating the need for innovative and effective approaches to achieve rational prescribing practices. The Ministries of Health in Nigeria and Uganda, in collaboration with partners, designed approaches to utilize private providers for delivery of basic child survival strategies and products to those populations less served by the public sector. These two distinct exploratory models built on lessons from similar efforts in SSA and elsewhere to develop approaches suited to the present situations in Nigeria and Uganda. This report describes the design, implementation, and results of those interventions"

Medicine prices surveys and proposed interventions to improve sustainable access to affordable medicines in 6 sub-Saharan African countries|Etudes des prix des medicaments et interventions proposeees pur ameliorer durablement l'acces aux medicaments dan


Expand view

This document brings together the outcomes of six surveys into medicine prices - for Ghana, Kenya, Mali, Tanzania, Chad and Uganda - and one for the East African Community (Kenya, Uganda and Tanzania) . The reports for Mali and Chad are written in French and the others in English

Missing the target #5 : improving AIDS drug access and advancing health care for all

December 2007

Expand view

This report documents how the mobilisation around AIDS is driving health systems advancement in China, Dominican Republic, Zimbabwe, Russia, Kenya, India, Cameroon, Zambia and Cambodia, and it highlights the need for improvements in broader systems of care and services to meet the needs of people living with HIV & AIDS and the communities in which they live. It also considers ARV procurement, registration and stock-outs in Argentina, Belize, Cambodia, China, Dominican Republic, India, Malawi, Morocco, Nigeria, Philippines, Russia, Uganda, Zambia, Zimbabwe

Pain relieving drugs in 12 African PEPFAR countries : mapping current providers, identifying current challenges, and enabling expansion of pain control provision in the management of HIV/AIDS

HARDING, Richard
et al
January 2007

Expand view

This study aims to identify current opioid prescribing services and regulatory bodies within 12 African PEPFAR (Presidents Emergency Plan for AIDS Relief ) countries, and to examine the barriers to, and appraise the potential for, expansion in the number of opioid providers, for people with HIV and AIDS according to the World Health Organization pain ladder. It concludes that while there are common issues raised by services and International Narcotics Control Board competent authorities, it is clear that these key stakeholders have concerns regarding the potential roll-out of opioids

Processes and issues for improving access to medicines : willingness and ability to utilise TRIPS flexibilities in non-producing countries

BAKER, Brook K.
August 2004

Expand view

This paper addresses the varied ways by which a non-medicine producing country may lawfully utilise the agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) flexibilities, primarily by importing. However, it also briefly discusses means for promoting local production through pharmaceutical capacity building and through both compulsory and voluntary licensing. To help decision-makers in understanding and evaluating the opportunities and constraints of each alternative, the paper briefly describes their respective advantages and disadvantages in terms of developing countries’ sustainable access to more affordable medicines, highlighting differing legal interpretations, political realities and pragmatic administrative and economic constraints

Report of a study on the civil society in Uganda : for the Royal Norwegian Embassy in Uganda

THUE, Nanna
July 2002

Expand view

This study describes and analyses civil society in Uganda, including how civic actors relate to each other and to government and its policies at central and local level . The study also aims to identify important actual issues, actors and roles as well as the main challenges for civil society and their implications for Norway’s future relations with Uganda

The push for local production, costs and benefits - a case study of Uganda’s Quality Chemicals|Africa Fighting Malaria policy paper

et al
September 2009

Expand view

This research report considers the challenges faced by a local pharmaceutical firm - Quality Chemicals - in Uganda, which was started up as a 'solution' to reducing the high cost of medicines and improving access to medicines. "...many burdens and barriers to access continue to seriously hinder the success of such enterprises. Indirect government subsidies to exporters selling into African markets, and pressure by donors and lobbyists on innovator producers to offer developing countries subsidised prices, actually undermine the competitiveness and viability of these nascent firms. Furthermore, the focus on drug pricing and local production can actually undermine the overall aim to increase access to medicines"

Uganda national drug policy

October 2002

Expand view

The Uganda national drug policy has been created to help ..."contribute to the attainment of a good standard of health by the population of Uganda, through ensuring the availability, accessibility and affordability of essential drugs of appropriate quality, safety and efficacy and by promoting their rational use"

Journal articles

The role of local manufacturers in improving access to essential medicines|Creating opportunities for the scale-up of local pharmaceutical production

November 2009

Expand view

The local manufacturing of pharmaceuticals is a hotly contested issue in many countries. It runs to the heart of key concerns such as quality, availability, and price of medicines. Some of the arguments of the local manufacturers are set out in this article by one of the co-chairs of the Medicines Transparency Alliance Uganda Council and Chairman of the Uganda Pharmaceutical Manufacturer's Association (UPMA)